StockNews.com Begins Coverage on Oncternal Therapeutics (NASDAQ:ONCT)
Research analysts at StockNews.com began coverage on shares of Oncternal Therapeutics (NASDAQ:ONCT – Get Free Report) in a note issued to investors on Wednesday. The firm set a “hold” rating on the stock. Oncternal Therapeutics Price Performance Shares of NASDAQ:ONCT opened at $0.53 on Wednesday. Oncternal Therapeutics has a 12-month low of $0.53 and a […]
Research analysts at StockNews.com began coverage on shares of Oncternal Therapeutics (NASDAQ:ONCT – Get Free Report) in a note issued to investors on Wednesday. The firm set a “hold” rating on the stock. Oncternal Therapeutics Price Performance Shares of NASDAQ:ONCT opened at $0.53 on Wednesday. Oncternal Therapeutics has a 12-month low of $0.53 and a […]
